Abstract
Nontypeable Haemophilus influenzae (NTHi), a typical mucosal pathogen largely responsible for respiratory infections and pediatric otitis media, has been increasingly recognized as a significant cause of invasive disease, especially in immunocompromised individuals. Lipooligosaccharide (LOS) is a conserved molecule with an important role in H. influenzae virulence and immune evasion, and it may be considered as a vaccine candidate. However, abilities of H. influenzae LOS to induce protective immune response are poorly understood. The goal of this study was to determine whether antibodies against LOS isolated from H. influenzae strains Eagan, Rd and NTHi 375 are present in the sera of normal individuals. Antigen specific IgG and IgM were studied in sera of 71 and 30 healthy adults, respectively. IgG specific for LOS of all three strains was ubiquitously present in our sample population while IgM specific for Eagan, Rd and NTHi 375 LOS compounds was detected in 37%, 63%, and 40% of samples, respectively. All tested serum samples exhibited bactericidal activity against all three H. influenzae strains; the removal of anti-LOS antibodies from the sera resulted in significant increases in bacterial survival of the corresponding strai...Continue Reading
References
Jan 1, 1989·The Pediatric Infectious Disease Journal·C C BrintonS W Wood
Dec 1, 1986·The Journal of Infectious Diseases·D MusherR Baughn
Nov 1, 1984·Mechanisms of Ageing and Development·G J LigthartG G Steinmann
Jul 28, 1995·Science·R D FleischmannJ M Merrick
Feb 24, 2001·Epidemiology and Infection·T LeinoA K Takala
Dec 18, 2001·Glycobiology·D W HoodJ C Richards
Apr 23, 2003·Vaccine·Xin-Xing GuJames F Battey
Mar 25, 2004·Journal of Leukocyte Biology·Timothy P PlackettElizabeth J Kovacs
Mar 24, 2005·Infection and Immunity·Ruth GriffinDerek W Hood
Mar 7, 2006·Lancet·Roman PrymulaLode Schuerman
Apr 29, 2006·Current Opinion in Infectious Diseases·Timothy F Murphy
Aug 2, 2006·Molecular BioSystems·Jianjun LiJames C Richards
May 23, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Raymond S W TsangJohn Wylie
Jun 30, 2007·Trends in Microbiology·Alice L Erwin, Arnold L Smith
Nov 17, 2007·Cell Host & Microbe·Zhao-Hua ZhouAbner Louis Notkins
Apr 22, 2008·The Journal of Infectious Diseases·S Y OhA J Pollard
Feb 26, 2009·Evolution; International Journal of Organic Evolution·Heather Maughan, Rosemary J Redfield
Mar 9, 2012·Clinical and Vaccine Immunology : CVI·Eli B NixMarina Ulanova
Jun 2, 2012·Frontiers in Bioscience (Elite Edition)·John R Schreiber
Jul 5, 2012·MBio·Jeroen D LangereisPeter W M Hermans
Nov 28, 2012·BMC Microbiology·Peter M PowerDerek W Hood
May 31, 2013·Glycobiology·Nicole R Luke-MarshallAnthony A Campagnari
Jan 31, 2014·Infection and Immunity·Charles V RosadiniBrian J Akerley
Mar 29, 2014·Clinical and Vaccine Immunology : CVI·Joshua ChoiMarina Ulanova
Jul 12, 2014·The Lancet Infectious Diseases·Johan Van EldereAllan W Cripps
Jul 24, 2014·MBio·Jeroen D Langereis, Jeffrey N Weiser
Aug 21, 2014·Vaccine·Kelly TownsendRay Borrow
Dec 6, 2014·Genome Announcements·Joshua Chang MellJunkal Garmendia
Citations
Feb 20, 2016·Expert Review of Vaccines·M Nadeem KhanMichael E Pichichero
Apr 28, 2017·Pathogens and Disease·Christian P AhearnTimothy F Murphy
Aug 16, 2018·PloS One·Eli B NixMarina Ulanova
Aug 14, 2019·Infection and Immunity·Mary Darby JacksonBrian J Akerley
Mar 17, 2021·Mass Spectrometry Reviews·David J Harvey